MicroMed Technology
Products to help patients suffering from congestive heart failure
About MicroMed Technology
MicroMedTech operates in the healthcare and biotechnology sectors, focusing on innovative solutions for cancer research and treatment. The company specializes in analyzing cellular differentiation and developing strategies to address the malfunctioning of cells and tissues in cancer patients. By providing detailed analysis and structured reports, MicroMedTech serves medical researchers, healthcare professionals, and academic institutions. The business model revolves around offering specialized research services and proprietary technologies that aid in understanding and combating cancer. Revenue is generated through service contracts, research grants, and technology licensing agreements. MicroMedTech aims to advance cancer research by offering precise and actionable insights into cellular behavior, ultimately contributing to more effective treatment protocols.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 1998
- Headquarters
- Houston, United States
- Open positions
- None listed
- Dealroom signal
- 17.3/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences, Biotechnology, Cardiology and cardiovascular, Non-Invasive medical devices and treatments, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Client focus
- b2b
- Links
- Website
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES D✓Equity / VC | Oct 2002 | $23M | $92M | Essex Woodlands Health Ventures · Mitsui Global Investment · SV Health Investors · Oxford Bioscience Partners | — |
| SERIES C✓Equity / VC | Mar 2000 | $18M | $70M | Undisclosed | — |
Growth signals
Latest recorded traffic for MicroMed Technology is 300 monthly website visits, up 42.9% over the last three months.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later4 investors entered at this stage
Essex Woodlands Health Ventures
Mitsui Global Investment
SV Health Investors- OPOxford Bioscience Partners
Other known investors2 additional known investors
EW Healthcare Partners
Western Technology Investment
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about MicroMed Technology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See MicroMed Technology’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.




